November 3, 2011 5:27 pm by Stephanie Baum | 0 Comments
In a bid to deepen its relationships with strategic partners in the pharmaceutical industry that have raised the profile of contract research organizations (CROs), Covance ( NYSE: CVD) has invested ...
Read more